Dr. Michael Tetzlaff's Conference Page

    Michael Tetzlaff is an Associate Professor at The University of Texas MD Anderson Cancer Center in Houston Texas in the Departments of Pathology (Section of Dermatopathology) and Translational and Molecular Pathology.  He is the Executive Officer for the Translational Research Program for The Alliance for Clinical Trials and directs the Imunohistochemistry C ore Laboratory for the Melanoma Moonshot Program at MD Anderson.  Dr. Tetzlaff earned his undergraduate degree from the University of Texas at Austin in the Plan II Honors program.  After spending two years studying Developmental Biology at The Max Planck Institute for Biophysical Chemistry in Goettingen, Germany, Dr. Tetzlaff earned his combined MD and PhD degrees in the Medical Scientist Training Program at Baylor College of Medicine in Houston, Texas, as a Hudson Scholar.  His PhD was in the laboratory of Dr. Stephen J. Elledge.

    Dr. Tetzlaff completed his residency in Anatomic Pathology in The Department of Pathology where he served as the Chief Resident, and after this, he completed his fellow ship in the Department of Dermatology at The Hospital of the University of Pennsylvania in Philadelphia, PA, where he trained with Dr. David Elder, Dr. George Xu and Dr. Rosalie Elenitsas.  Following his training, Dr. Tetzlaff began his academic career at MD Anderson. 


    In addition to his busy clinical service schedule, Dr. Tetzlaff leads a number of research projects exploring histopathologic, immunologic and molecular prognostic indicators in mucosal melanomas (specifically, those arising on the vulva, vagina and anorectum); molecular-genetic alterations in ocular and extra-ocular sebaceous carcinoma; and immunologic surrogates of prognosis in Merkel Cell Carcinoma.  In addition, he is an active collaborator on a number of clinical trials in melanoma at MD Anderson.  He serves on the Editorial Boards of Human Pathology, American Journal of Clinical Pathology and Applied Immunohistochemistry &Molecular Morphology.  He is an author of over 100 published peer-reviewed manuscripts.